Search Results for: REL

325 interactions involving REL - REL proto-oncogene, NF-kB subunit found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Symbol Description Pathways Hide Drugs Hide Diseases Hide
SIN3A SIN3 transcription regulator family member A
  • SUMOylation of transcription cofactors
  • Regulation of lipid metabolism by PPARalpha
  • NoRC negatively regulates rRNA expression
  • RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
  • Loss of MECP2 binding ability to 5mC-DNA
  • Regulation of MECP2 expression and activity
  • MECP2 regulates neuronal receptors and channels
  • MECP2 regulates transcription of neuronal ligands
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
  • STAT3 nuclear events downstream of ALK signaling
  • Cytoprotection by HMOX1
  • Regulation of MITF-M-dependent genes involved in apoptosis
  • Regulation of MITF-M-dependent genes involved in cell cycle and proliferation
  • Factors involved in megakaryocyte development and platelet production
SIX1 SIX homeobox 1
  • Formation of the ureteric bud
  • Contiguous gene deletion syndrome involving EYA1, including: Oto-facio-cervical syndrome (OFC); Branchiootic syndrome 1 (BOS1); Branchio-oto-renal syndrome (BOR)
SLC39A13 solute carrier family 39 member 13
  • Ehlers-Danlos syndrome (EDS), including: EDS classical type (EDS1/2); EDS hypermobility type (EDS3); EDS vascular type (EDS4); EDS kyphoscoliosis type (EDS6); EDS arthrochalasia type (EDS7A/7B); EDS dermatospraxis type (EDS7C); EDS autosomal recessive cardiac valvular form (EDSCV); EDS musculocontractural type (EDSMC); EDS progeroid form (EDSP); Tenascin-X deficiency (TNXD); Brittle cornea syndrome (EDS6B); EDS-like spondylocheiro dysplasia (SCD-EDS)
SLC41A3 solute carrier family 41 member 3
SLC6A12 solute carrier family 6 member 12
  • Amino acid transport across the plasma membrane
  • Creatine metabolism
  • Reuptake of GABA
  • Guvacine
SMG9 SMG9 nonsense mediated mRNA decay factor
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
SNRNP25 small nuclear ribonucleoprotein U11/U12 subunit 25
  • mRNA Splicing - Minor Pathway
SP1 Sp1 transcription factor
  • PPARA activates gene expression
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Activation of gene expression by SREBF (SREBP)
  • Oncogene Induced Senescence
  • RNA polymerase II transcribes snRNA genes
  • RNA polymerase II transcribes snRNA genes
  • Estrogen-dependent gene expression
  • SARS-CoV-1 targets host intracellular signalling and regulatory pathways
  • Regulation of CDH11 gene transcription
  • Regulation of CDH11 gene transcription
  • Positive Regulation of CDH1 Gene Transcription
  • NFE2L2 regulating tumorigenic genes
  • TGFBR3 expression
SPATC1L spermatogenesis and centriole associated 1 like
SPG21 SPG21 abhydrolase domain containing, maspardin
  • Hereditary spastic paraplegia (SPG)
SPRY1 sprouty RTK signaling antagonist 1
  • EGFR downregulation
SRF serum response factor
  • RHO GTPases Activate Formins
  • NGF-stimulated transcription
  • NGF-stimulated transcription
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • Cardiogenesis
  • Regulation of NPAS4 gene transcription
STAMBPL1 STAM binding protein like 1
  • Metalloprotease DUBs
STK16 serine/threonine kinase 16
  • Fostamatinib
SULT2B1 sulfotransferase family 2B member 1
  • Adenosine 3',5'-diphosphate
  • Pregnenolone
  • N-cyclohexyltaurine
SUOX sulfite oxidase
  • Sulfide oxidation to sulfate
  • {[2-Amino-4-oxo-6,7-di(sulfanyl-κS)-3,5,5a,8,9a,10-hexahydro-4H-pyrano[3,2-g]pteridin-8-yl]methyl dihydrogenato(2-) phosphate}(dioxo)sulfanylmolybdenum
SZT2 SZT2 subunit of KICSTOR complex
  • Amino acids regulate mTORC1
TBC1D21 TBC1 domain family member 21
TBC1D22B TBC1 domain family member 22B
TBP TATA-box binding protein
  • HIV Transcription Initiation
  • RNA Polymerase II HIV Promoter Escape
  • Transcription of the HIV genome
  • SIRT1 negatively regulates rRNA expression
  • NoRC negatively regulates rRNA expression
  • B-WICH complex positively regulates rRNA expression
  • RNA Polymerase II Pre-transcription Events
  • Regulation of TP53 Activity through Phosphorylation
  • RNA polymerase II transcribes snRNA genes
  • RNA polymerase II transcribes snRNA genes
  • RNA Polymerase I Transcription Initiation
  • RNA Polymerase I Transcription Initiation
  • RNA Polymerase I Promoter Escape
  • RNA Polymerase II Promoter Escape
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase I Transcription Termination
  • RNA Polymerase III Abortive And Retractive Initiation
  • RNA Polymerase II Transcription Initiation
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • RNA Polymerase III Transcription Initiation From Type 1 Promoter
  • RNA Polymerase III Transcription Initiation From Type 1 Promoter
  • RNA Polymerase III Transcription Initiation From Type 2 Promoter
  • RNA Polymerase III Transcription Initiation From Type 2 Promoter
  • RNA Polymerase III Transcription Initiation From Type 3 Promoter
  • RNA Polymerase III Transcription Initiation From Type 3 Promoter
  • Estrogen-dependent gene expression
  • Spinocerebellar ataxia (SCA); Machado-Joseph disease (SCA3)

Page 14 out of 17 pages